Anonymous ID: d25c2c March 27, 2026, 7:28 a.m. No.24433650   🗄️.is 🔗kun   >>3722 >>3833 >>3984 >>4173 >>4210

Justice Department opens investigations into three medical schools over alleged race-based admission

 

The investigations, led by Assistant Attorney General Harmeet Dhillon, are into Stanford University, the Ohio State University and the University of California San Diego.

 

he Justice Department's Office of Civil Rights has launched investigations into three U.S. medical schools over concerns about race-based discrimination in their admission processes.

 

The investigations, led by Assistant Attorney General Harmeet Dhillon, are into Stanford and Ohio State universities and the University of California San Diego, according to The Hill newspaper.

 

Dhillon's office requested the schools provide seven years of data about applicants’ race, standardized test scores, relations to donors, zip codes and other educational information by April 24.

 

"Launching a series of civil rights investigations," Dhillon posted on X. "Another day in paradise!"

 

The department has not commented on the investigations so far, but the schools confirmed they received the letters and said they would respond appropriately.

 

"Ohio State is fully compliant with all state and federal regulations and legal rulings regarding admissions," Benjamin Johnson, a spokesman for The Ohio State University, told NBC News.

 

The investigations come after the Trump administration investigated multiple schools last year over their diversity, equity and inclusion policies. The DOJ also sued Harvard last month for withholding its race-based admission documents.

 

https://justthenews.com/politics-policy/education/justice-department-opens-investigations-three-medical-schools-over

Anonymous ID: d25c2c March 27, 2026, 7:34 a.m. No.24433684   🗄️.is 🔗kun   >>3722 >>3833 >>3984 >>4173 >>4210

Study Indicates Nattokinase Can Reduce Plaque that Is Linked to Heart Attack and Stroke By 36%

March 26, 2026

 

Nattokinase is an enzyme extracted from natto, a traditional Japanese fermented soybean food, known for its potential to break down blood clots, improve blood flow, and reduce blood pressure.

A recent study from China of 1,062 participants with evidence of mild atherosclerosis observed to have high levels of lipids (e.g., triglycerides and cholesterol) showed that 10,800 FU (fibrinolytic units) per day of nattokinase is associated with a 36% reduction in artery plaque size. The researchers noted that an effective treatment of atherosclerosis and hyperlipidemia is in the range of 6,000 to 12,000 FU daily, which is much higher than 2,000 FU, a recommended dose in Europe.

 

Nattokinase has also been used to treat people who received that COVID-19 injection.

 

NOTE: The Need To Know News does not give medical advice or endorse any health treatment, but reports the news. Please consult your own medical health experts before beginning any medical treatment.

 

more:

 

https://needtoknow.news/2026/03/study-indicates-nattokinase-can-reduce-plaque-that-is-linked-to-heart-attack-and-stroke-by-36/